Advancing global sustainability and human health are major challenges of this century. To confront these challenges, groundbreaking genomic technologies emerge as pivotal solutions. However, our understanding of the genomic diversity of crucial organisms like fungi, plant and humans remains incomplete.
This conference aims to showcase:
Recent genomic breakthroughs in sustainable biomanufacturing, focusing on the engineering of microorganisms to produce secondary metabolites at scale.
The comprehensive exploration of the mutational landscape in major diseases such as cancer, infectious disorders, and obesity at the personalized level in clinical diagnostics.
Wellcome Sanger Institute, UK
DTU Biosustain, CFB
Aalborg University
Chalmers University
University of Zurich
University of Copenhagen
Novozymes
CEO & Co-Founder at gMendel | BioTech and MedTech Executive
Ginkgo Bioworks
OR
Zoom at
https://dtudk.zoom.us/j/65606703037?pwd=H4hCljNCUwm08VYcOxprtESWyOehNV.1
Meeting ID: 656 0670 3037
Passcode: 754449
Deadline for signup: August 30, 2024